UnknownNot Applicable

Treatment and Vaccine Development of Mycoplasma Pneumoniae

Taiwan100 participantsStarted 2018-11-10

Plain-language summary

A randomized clinical trial comparing treatment effectiveness of azithromycin and doxycycline for pediatric Mycoplasma pneumonia.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children aged 0-18 years, admitted due to lower respiratory tract infections. Mycoplamsa pneumonia is diagnosed. * The diagnosis is made within 72 hours after fever onset. * The patient and his/her guardians are willing to participate the study and able to follow the instruction. Exclusion Criteria: * None

What they're measuring

Defervescence

Timeframe: Up to 10 days

Trial details

NCT IDNCT03911440

SponsorNational Taiwan University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-31

Contact for this trial

Li-Min Huang, MD, PhD

886-2-23123456 lmhuang@ntu.edu.tw

View on ClinicalTrials.gov More Atypical Pneumonia trials